IMA
NASDAQ · Pharmaceuticals
Imagenebio Inc
$5.69
+0.00 (+0.00%)
Open$5.92
Previous Close$5.69
Day High$5.92
Day Low$5.48
52W High$18.00
52W Low$5.35
Volume—
Avg Volume36.2K
Market Cap63.64M
P/E Ratio—
EPS$-5.86
SectorPharmaceuticals
Analyst Ratings
Buy
7 analysts
Price Target
+111.2% upside
Current
$5.69
$5.69
Target
$12.02
$12.02
$8.98
$12.02 avg
$15.27
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 47.00M | 44.29M | 39.41M |
| Net Income | 6.79M | 4.55M | 5.11M |
| Profit Margin | 14.5% | 10.3% | 13.0% |
| EBITDA | 10.10M | 9.89M | 9.22M |
| Free Cash Flow | 2.61M | 3.33M | 3.29M |
| Rev Growth | -8.8% | -0.9% | +2.4% |
| Debt/Equity | 0.50 | 0.50 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |